Global Multiple Myeloma Market Analysis, 2020

By Test Type (Blood, Biopsy, Imaging [X-rays, CT scan (Computed tomography scan), Magnetic resonance imaging (MRI) scans, Positron emission tomography (PET) scan, Echocardiogram (ECHO)], Others (Urine test, etc.)), By Medication (Chemotherapy [Anthracycline antiobiotic, Alkylating agent], Targeted Therapies [Immunomodulatory Drugs, Monoclonal Antibodies, Proteasome Inhibitors, Histone Deacetylase (HDAC) Inhibitors, Others (Nuclear export inhibitor etc.)], Radiation Therapy, Stem Cell Transplant, Supportive Treatments), By End-User (Hospitals & Specialty Centers, Laboratories, Others), By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa), By Country (US, Canada, Mexico, Brazil, UK, Germany, France, Spain, Italy, The Netherlands, China, Japan, South Korea, India, South East-Asia, UAE, Saudi Arabia, South Africa)

  • Healthcare
  • Jul 2020
  • 204
  • HC22029